×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
CareDx Announces IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE®
INBRAIN Neuroelectronics has been awarded a €4 million grant from Spain’s PERTE Chip Program to advance graphene-based brain-computer interfaces
06 May 2025
INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision
...
IFF Pharma Solutions launches METHOCEL™ HPMC with low nitrite content to mitigate nitrosamine risks
Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity
Pharmaceutical Leader Nia Tatsis, Ph.D., Appointed to Odyssey Therapeutics’ Board of Directors
Elizabeth Nanouris Named VP of Business Operations at InFocus Clinical Research
Roche Receives FDA 510(k) Clearance for New cobas® eplex Respiratory Pathogen Panel 3, Enabling Customized Respiratory Testing to Meet Local Patient Needs
By
Roche Diagnostics
Roche Diagnostics
02 Nov 2026
Superpower Launches Peptide Services, Connecting Comprehensive Blood Testing With Prescription Peptide Care
By
Superpower
Superpower
02 Nov 2026
Superpower Launches Peptide Services, Connecting Comprehensive Blood Testing With Prescription Peptide Care
By
Superpower
Superpower
02 Nov 2026
Superpower Launches Peptide Services, Connecting Comprehensive Blood Testing With Prescription Peptide Care
By
Superpower
Superpower
02 Nov 2026
Wolfspeed Introduces Transparent Silicon Carbide Technology Commercially for Augmented Reality and Quantum Computing.
By
Wolfspeed, Inc
Wolfspeed, Inc
30 Oct 2026
Twist Bioscience Launched MRD Express for Faster Turnaround
By
Twist Bioscience Corporation
Twist Bioscience Corporation
29 Oct 2026
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Most Popular
A convenient and cost-effective way to treat sickle cell disease may be offered by Vascarta's patented transdermal drug candidate
By
Vascarta Inc
Feb 20
EU Approves Expanded Label for Opdivo® + AVD in Advanced Hodgkin Lymphoma
By
Bristol Myers Squibb
Jun 01
Orsini begins distribution of CASGEVY® (exagamglogene autotemcel), a gene-editing therapy
By
Orsini
Nov 14
November
2026
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe to Our Monthly Newsletter
Subscribe to Pharmaceutical Era’s monthly newsletter,
Pharmaceutical Leaders Digest
®, to receive timely updates from across the pharmaceutical industry.
I agree with the
Terms and conditions
×
and the
Privacy policy
×
Please enable the javascript to submit this form
Subscribe
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand